Funding for this research was provided by:
National Natural Science Foundation of China (81872506)
Received: 16 March 2022
Accepted: 29 August 2022
First Online: 10 September 2022
: The study protocol was approved by the China registered clinical trial ethics committee (ChiECRCT-2011034). The study was conducted in accordance with the Declaration of Helsinki. Each participant provided informed consent prior to their enrollment.
: Not applicable.
: The authors declare that they have no competing interests.